Insights
Access our latest insights & resources
Content Type: Research
Advisory Committee’s Split Decision on Biogen’s Tofersen
Policy & Legal, Research
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read more
ETF Inflows Signal Investors Caution as the U.S. Debt Ceiling Deadling Looms
ETF & Mutual Fund, Research
Gold ETFs have taken in $2.7 billion this year through...
Read more
U.S. Banks: All Eyes on Fed Bank Supervision
Fundamental, Research
Banks face many headwinds in the eyes of investors and policymakers...
Read more
Mitigation Expectations for Medicare Advantage Rate Notice
Policy & Legal, Research
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
In the TikTok Kerfuffle, Politics Will Win Out over National Security
Policy & Legal, Research
Policy to win out over national security concerns in TikTok debate...
Read more
Big Tech Cost Cuts: META Taking a Page From the Apple Efficiency Playbook
Fundamental, Research
META to rebound from heavy job cuts in 2023...
Read more
Lowry Mid-Week Commentary Week of March 15, 2023
Research, Technical
Revisitation of previous week's comments reversal and sell-off...
Read more
European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key
Fundamental, Research
How European Pharma fared versus consensus estimates...
Read more
Hydrogen Update: Will Treasury Exclude Existing Nukes & Renewables?
Policy & Legal, Research
We believe 2023 will be a foundational year for clean hydrogen development in the U.S., with two important federal issues on the horizon...
Read moreInteractive Media: Implications of a Potential Tik Tok Ban to Competitors
Fundamental, Research
Some social media companies poised to benefit from potential TikTok ban...
Read more